Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chanakya Kodishala

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Rheumatology (Oxford, England)|August 10, 2022
Low-dose rituximab is efficacious in refractory idiopathic inflammatory myopathiesRamya Janardana, S N Amin, Liza Rajasekhar, et al.
Seminars in Arthritis and Rheumatism|October 16, 2024
The impact of cardiovascular and cerebrovascular disease on the risk of dementia in rheumatoid arthritis: A mediation analysisEdward Lovering, Chanakya Kodishala, Roslin Jose George, et al.
RMD Open|August 5, 2025
Multimorbidity burden predicts lower likelihood of remission and higher likelihood of disease flare in patients with rheumatoid arthritisDaniel Montes, Elena Myasoedova, Chanakya Kodishala, et al.
Rheumatology Advances in Practice|June 29, 2026
Assessing the diagnostic utility of baseline creatine kinase levels in patients with suspected idiopathic inflammatory myopathies and neuromuscular disordersNikola Wilk, Filipe O Pinheiro, Linn Renken, et al.
The Journal of Rheumatology|July 15, 2022
Risk Factors for Dementia in Patients With Incident Rheumatoid Arthritis: A Population-Based Cohort StudyChanakya Kodishala, Cassondra A Hulshizer, Vanessa L Kronzer, et al.
The Journal of Rheumatology|November 15, 2022
Dr. Kodishala et al replyChanakya Kodishala, Cassondra A Hulshizer, Vanessa L Kronzer, et al.
Rheumatology (Oxford, England)|October 23, 2023
Neuropathologic evaluation of cerebrovascular disease in patients with rheumatoid arthritisRachel A Larsen, Eleni Constantopoulos, Chanakya Kodishala, et al.
Lupus|February 2, 2023
Risk factors associated with COVID-19 in systemic lupus erythematosus: Results from a longitudinal prospective cohortAbhishek Patil, Vineeta Shobha, Padmanabha Shenoy, et al.
Rheumatology (Oxford, England)|September 12, 2023
Comparison of clinical features between patients with anti-synthetase syndrome and dermatomyositis: results from the MYONET registryRyan Malcolm Hum, James B Lilleker, Janine A Lamb, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Rheumatology (Oxford, England)|August 10, 2022
Low-dose rituximab is efficacious in refractory idiopathic inflammatory myopathiesRamya Janardana, S N Amin, Liza Rajasekhar, et al.
Seminars in Arthritis and Rheumatism|October 16, 2024
The impact of cardiovascular and cerebrovascular disease on the risk of dementia in rheumatoid arthritis: A mediation analysisEdward Lovering, Chanakya Kodishala, Roslin Jose George, et al.
RMD Open|August 5, 2025
Multimorbidity burden predicts lower likelihood of remission and higher likelihood of disease flare in patients with rheumatoid arthritisDaniel Montes, Elena Myasoedova, Chanakya Kodishala, et al.
Rheumatology Advances in Practice|June 29, 2026
Assessing the diagnostic utility of baseline creatine kinase levels in patients with suspected idiopathic inflammatory myopathies and neuromuscular disordersNikola Wilk, Filipe O Pinheiro, Linn Renken, et al.
The Journal of Rheumatology|July 15, 2022
Risk Factors for Dementia in Patients With Incident Rheumatoid Arthritis: A Population-Based Cohort StudyChanakya Kodishala, Cassondra A Hulshizer, Vanessa L Kronzer, et al.
The Journal of Rheumatology|November 15, 2022
Dr. Kodishala et al replyChanakya Kodishala, Cassondra A Hulshizer, Vanessa L Kronzer, et al.
Rheumatology (Oxford, England)|October 23, 2023
Neuropathologic evaluation of cerebrovascular disease in patients with rheumatoid arthritisRachel A Larsen, Eleni Constantopoulos, Chanakya Kodishala, et al.
Lupus|February 2, 2023
Risk factors associated with COVID-19 in systemic lupus erythematosus: Results from a longitudinal prospective cohortAbhishek Patil, Vineeta Shobha, Padmanabha Shenoy, et al.
Rheumatology (Oxford, England)|September 12, 2023
Comparison of clinical features between patients with anti-synthetase syndrome and dermatomyositis: results from the MYONET registryRyan Malcolm Hum, James B Lilleker, Janine A Lamb, et al.
Pageof 1